Figure 1.
Clinical outcomes according to MALT-IPI risk groups in the testing set. Kaplan-Meier estimates for EFS (A), PFS (B), CSS (C), and OS (D) in the testing set from the IELSG-19 clinical trial database.

Clinical outcomes according to MALT-IPI risk groups in the testing set. Kaplan-Meier estimates for EFS (A), PFS (B), CSS (C), and OS (D) in the testing set from the IELSG-19 clinical trial database.

Close Modal

or Create an Account

Close Modal
Close Modal